Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Pulmonary Arterial Hypertension is characterized by a progressive increase in pulmonary vascular resistance inducing shortness of breath and exercise intolerance. We aim to correlate cardiac function (evaluated at rest by right heart catheterism and RMN) to exercise capacity (evaluated by endurance time at 75% of maximal workout), in prevalent patients with pulmonary arterial hypertension, and their evolution at three and twelve months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
49 participants in 2 patient groups
Loading...
Central trial contact
Laurent BERTOLETTI, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal